Loading…
JV

Julienne Vaillancourt

FDA
Rare Disease Liaison, CBER
As the Rare Disease Liaison for FDA’s Center for Biologics Evaluation and Research (CBER) in the Office of the Director, CAPT Julienne Vaillancourt coordinates CBER's Rare Disease Program, which facilitates the development and timely approval of biologics for adults and children with rare diseases. She works closely with colleagues in the CDER Rare Diseases Program and the FDA/Office of Orphan Products Development, and interacts with patient groups. Previously she was a regulatory project manager (RPM) and team leader in CBER’s Office of Vaccines Research and Review for a total of 19 years. She is a pharmacist in the US Public Health Service Commissioned Corps and has a Master of Public Health degree from Boston University.

My Speakers Sessions

Wednesday, June 26
 

9:00am PDT